百洋医药(301015.SZ)与君信签署人血白蛋白产品相关经销协议

Core Viewpoint - Baiyang Pharmaceutical (301015.SZ) has signed a distribution agreement with Guangzhou Junxin Pharmaceutical Co., Ltd. on November 4, 2025, granting Baiyang exclusive rights to promote, sell, and distribute the product Anbomei® in specific markets during the agreement period [1] Group 1 - The agreement specifies the rights and obligations of both parties involved [1] - Junxin is a subsidiary of Jetabelin (Asia Pacific) Limited, which operates sales in China [1] - Baiyang has been collaborating with Jetabelin on the retail market for Anbomei® since March 2021, and this agreement expands their cooperation into broader retail and hospital markets, excluding specific lists provided by Junxin [1]